Histoplasmosis in Inflammatory Bowel Disease Patients on Tumor Necrosis Factor-a Medications

被引：0
|
作者：
Jansson-Knodell, Claire [1 ]
Moors, Courtney [1 ]
Loftus, Edward V., Jr. [1 ]
Walker, Randall [1 ]
Enzler, Mark [1 ]
Virk, Abinash [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
671
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 50 条
  • [41] Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease
    Kirchgesner, Julien
    Desai, Rishi J.
    Beaugerie, Laurent
    Schneeweiss, Sebastian
    Kim, Seoyoung C.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) : 314 - +
  • [42] Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease
    Ioannis Androulakis
    Christos Zavos
    Panagiotis Christopoulos
    George Mastorakos
    Maria Gazouli
    World Journal of Gastroenterology, 2015, 21 (47) : 13205 - 13211
  • [43] Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure
    Yan Jiang
    Oliver Lin
    Sidhartha R. Sinha
    Digestive Diseases and Sciences, 2017, 62 : 1597 - 1606
  • [44] Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
    Bortlik, Martin
    Duricova, Dana
    Machkova, Nadezda
    Hruba, Veronika
    Lukas, Martin
    Mitrova, Katarina
    Romanko, Igor
    Bina, Vladislav
    Malickova, Karin
    Kolar, Martin
    Lukas, Milan
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (02) : 196 - 202
  • [45] The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease
    Koutroubakis, Ioannis E.
    Ramos-Rivers, Claudia
    Regueiro, Miguel
    Koutroumpakis, Efstratios
    Click, Benjamin
    Schwartz, Marc
    Swoger, Jason
    Baidoo, Leonard
    Hashash, Jana G.
    Barrie, Arthur
    Dunn, Michael A.
    Binion, David G.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (07) : 1587 - 1593
  • [46] Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases
    Ward, Daniel
    Andersen, Nynne Nyboe
    Gortz, Sanne
    Iversen, Aske Thorn
    Allin, Kristine Hojgaard
    Beaugerie, Laurent
    Kirchgesner, Julien
    Jess, Tine
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (01) : 135 - 143
  • [47] Tumor Necrosis Factor-a Signaling in Macrophages
    Parameswaran, Narayanan
    Patial, Sonika
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2010, 20 (02): : 87 - 103
  • [48] New Ascites and Omental Thickening in Ulcerative Colitis Disseminated Histoplasmosis in an Inflammatory Bowel Disease Patient Receiving Tumor Necrosis Factor Inhibitor Therapy
    Chen, Joy C. Y.
    Halawi, Houssam
    Loftus, Conor G.
    GASTROENTEROLOGY, 2019, 157 (05) : E10 - E11
  • [49] FECAL AND SYSTEMIC TUMOR-NECROSIS-FACTOR IN EXPERIMENTAL INFLAMMATORY BOWEL-DISEASE
    NEILLY, PJD
    CAMPBELL, GR
    ANDERSON, NH
    GARDINER, KR
    KIRK, SJ
    ROWLANDS, BJ
    BRITISH JOURNAL OF SURGERY, 1994, 81 (12) : 1817 - 1817
  • [50] Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel Disease
    Abdullah, Israa
    Alhendi, Ghadeer
    Alhadab, Anwar
    Alasfour, Hajer
    Shehab, Mohammad
    FRONTIERS IN MEDICINE, 2021, 8
12345